Category: Art

Short Bowel Syndrome Market: Global Industry Analysis and Forecast 2027 Based on regional segment, the Short Bowel Syndrome market is sub-segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the market during forecasted period. The rising prescriptions for Glucagon-like Peptide treatment in the U.S. is anticipated to driver the growth for the North America short bowel syndrome market. Additionally, the fact that glutamine and growth hormone are only permitted in the U.S. for treating SBS is anticipated to keep North America in the lead. The increasing awareness about short bowel syndrome amongst consumers and outstanding reimbursement strategies are anticipated to fuel the regional market during forecast period.